<DOC>
	<DOCNO>NCT02921360</DOCNO>
	<brief_summary>The aim study determine whether early administration aspirin acute ischemic stroke patient treat systemic thrombolysis safe improve outcome due decrease number early rethromboses .</brief_summary>
	<brief_title>Early Administration Aspirin Patients With Acute Ischemic Stroke Treated With Systemic Thrombolysis</brief_title>
	<detailed_description>According current guideline ( European Stroke Organisation , 2009 ; American Heart Association-American Stroke Association , 2013 ) systemic thrombolysis ischemic stroke patient recommend ( class C ) start antithrombotic therapy ( include antiplatelets anticoagulant ) 24 hour go alteplase ( rtPA , recombinant tissue plasminogen activator ) administration . Meanwhile rtPA wery short lifetime blood ( T1/2 4-6 minute ) . Some retrospective study find early administration antithrombotics ( 8-16 hour ) systemic thrombolysis improve functional outcome increase risk haemorrhage . The investigator suggest control prospective trial recognise risk benefit early administration aspirin ( 12 hour ) rtPA therapy patient acute ischemic stroke .</detailed_description>
	<mesh_term>Stroke</mesh_term>
	<mesh_term>Ischemia</mesh_term>
	<mesh_term>Brain Ischemia</mesh_term>
	<mesh_term>Aspirin</mesh_term>
	<criteria>acute ischemic stroke patient treat rtPA mRS score current stroke &lt; 4 NIHSS score rtPA treatment &lt; 25 contraindication treatment aspirin contraindication fot iodinate radiocontrast agent administration intracranial haemorrhage rtPA treatment</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>thrombolytic therapy</keyword>
	<keyword>tissue plasminogen activator</keyword>
	<keyword>aspirin</keyword>
</DOC>